Medtronic Plc Earnings

Medtronic Plc’s revenue jumped 3.94% since last year same period to $8927Mn in the Q2 2025. On a quarterly growth basis, Medtronic Plc has generated 7.66% jump in its revenue since last 3-months.

Medtronic Plc’s net profit jumped 61.62% since last year same period to $1057Mn in the Q2 2025. On a quarterly growth basis, Medtronic Plc has generated -18.32% fall in its net profits since last 3-months.

Medtronic Plc’s net profit margin jumped 55.5% since last year same period to 11.84% in the Q2 2025. On a quarterly growth basis, Medtronic Plc has generated -24.13% fall in its net profit margins since last 3-months.

Medtronic Plc’s price-to-earnings ratio after this Q2 2025 earnings stands at 23.92.

Medtronic Plc’s earning per share (EPS) estimates for the current quarter stand at 1.58 - a 16.18% jump from last quarter’s estimates.

Medtronic Plc’s earning per share (EPS) estimates for the current year stand at 1.58.

Medtronic Plc’s earning per share (EPS) jumped 10.96% since last year same period to 1.62 in the Q2 2025. This indicates that the Medtronic Plc has generated 10.96% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Medtronic Plc’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Medtronic Plc’s return on equity (ROE) stands at 0.1.

Medtronic Plc declared 0.71 dividend per share during the earnings announcement for Q2 2025.